| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | - | -10,810.164 | -10,357.354 | -24,686.526 |
| Net Profit Margin | - | - | - | - |
| Debt to Asset Ratio | 6.962 | 8.233 | 8.476 | 13.731 |
| Cash Ratio | 1,435.15 | 998.991 | 873.088 | 271.121 |
| Quick Ratio | 1,785.194 | 1,426.618 | 1,370.18 | 872.339 |
| Current Ratio | 1,785.194 | 1,426.618 | 1,370.18 | 872.339 |
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)